77 related articles for article (PubMed ID: 10415022)
21. Tissue- and epitope-specific mechanisms account for the diverse effects of anti-CD44 antibodies on the maintenance of primitive hematopoietic progenitors in vitro.
Müller-Sieburg CE; Deryugina E; Khaldoyanidi S; O'Rourke A
Blood Cells Mol Dis; 2000 Aug; 26(4):291-302. PubMed ID: 11042030
[TBL] [Abstract][Full Text] [Related]
22. Characterization of a functional hyaluronan-binding domain from the human CD44 molecule expressed in Escherichia coli.
Banerji S; Day AJ; Kahmann JD; Jackson DG
Protein Expr Purif; 1998 Dec; 14(3):371-81. PubMed ID: 9882571
[TBL] [Abstract][Full Text] [Related]
23. Role of hyaluronan and CD44 in in vitro branching morphogenesis of ureteric bud cells.
Pohl M; Sakurai H; Stuart RO; Nigam SK
Dev Biol; 2000 Aug; 224(2):312-25. PubMed ID: 10926769
[TBL] [Abstract][Full Text] [Related]
24. Hyaluronic acid synthase-1 expression regulates bladder cancer growth, invasion, and angiogenesis through CD44.
Golshani R; Lopez L; Estrella V; Kramer M; Iida N; Lokeshwar VB
Cancer Res; 2008 Jan; 68(2):483-91. PubMed ID: 18199543
[TBL] [Abstract][Full Text] [Related]
25. Phorbol myristate acetate stimulates the dimerization of CD44 involving a cysteine in the transmembrane domain.
Liu D; Sy MS
J Immunol; 1997 Sep; 159(6):2702-11. PubMed ID: 9300690
[TBL] [Abstract][Full Text] [Related]
26. Stromal derived factor-1 alpha (SDF-1 alpha) induces CD4+ T cell apoptosis via the functional up-regulation of the Fas (CD95)/Fas ligand (CD95L) pathway.
Colamussi ML; Secchiero P; Gonelli A; Marchisio M; Zauli G; Capitani S
J Leukoc Biol; 2001 Feb; 69(2):263-70. PubMed ID: 11272277
[TBL] [Abstract][Full Text] [Related]
27. A role for CD44 in an antigen-induced murine model of pulmonary eosinophilia.
Katoh S; Matsumoto N; Kawakita K; Tominaga A; Kincade PW; Matsukura S
J Clin Invest; 2003 May; 111(10):1563-70. PubMed ID: 12750406
[TBL] [Abstract][Full Text] [Related]
28. Synthetic 1,4-anthracenedione analogs induce cytochrome c release, caspase-9, -3, and -8 activities, poly(ADP-ribose) polymerase-1 cleavage and internucleosomal DNA fragmentation in HL-60 cells by a mechanism which involves caspase-2 activation but not Fas signaling.
Perchellet EM; Wang Y; Weber RL; Sperfslage BJ; Lou K; Crossland J; Hua DH; Perchellet JP
Biochem Pharmacol; 2004 Feb; 67(3):523-37. PubMed ID: 15037204
[TBL] [Abstract][Full Text] [Related]
29. Differences in the binding of blocking anti-CD11b monoclonal antibodies to the A-domain of CD11b.
Violette SM; Rusche JR; Purdy SR; Boyd JG; Cos J; Silver S
J Immunol; 1995 Sep; 155(6):3092-101. PubMed ID: 7673724
[TBL] [Abstract][Full Text] [Related]
30. Identification of two regions in the cytoplasmic domain of CD44 through which PMA, calcium, and foskolin differentially regulate the binding of CD44 to hyaluronic acid.
Liu D; Liu T; Sy MS
Cell Immunol; 1998 Dec; 190(2):132-40. PubMed ID: 9878114
[TBL] [Abstract][Full Text] [Related]
31. CD44 is a cytotoxic triggering molecule on human polymorphonuclear cells.
Pericle F; Sconocchia G; Titus JA; Segal DM
J Immunol; 1996 Nov; 157(10):4657-63. PubMed ID: 8906846
[TBL] [Abstract][Full Text] [Related]
32. Hyaluronate binding assay study of transfected CD44 V4-V7 isoforms into the human gastric carcinoma cell line SC-M1.
Harn HJ; Shen KL; Liu CA; Ho LI; Yang LS; Yueh KC
J Pathol; 1998 Mar; 184(3):291-6. PubMed ID: 9614382
[TBL] [Abstract][Full Text] [Related]
33. Apoptosis through CD95 (Fas/APO-1), but not a CD40/CD95 chimeric receptor, is inhibited by phorbol-12-myristate-13-acetate.
Rudert F; Wang Y; Lindridge E; Watson J
DNA Cell Biol; 1997 Feb; 16(2):197-205. PubMed ID: 9052740
[TBL] [Abstract][Full Text] [Related]
34. Targeting dendritic cells with CD44 monoclonal antibodies selectively inhibits the proliferation of naive CD4+ T-helper cells by induction of FAS-independent T-cell apoptosis.
Termeer C; Averbeck M; Hara H; Eibel H; Herrlich P; Sleeman J; Simon JC
Immunology; 2003 May; 109(1):32-40. PubMed ID: 12709015
[TBL] [Abstract][Full Text] [Related]
35. PF-03475952: a potent and neutralizing fully human anti-CD44 antibody for therapeutic applications in inflammatory diseases.
Runnels HA; Weber GL; Min J; Kudlacz EM; Zobel JF; Donovan CB; Thiede MA; Zhang J; Alpert RB; Salafia MA; Milici AJ; Burdette D; Bell RR; Beebe JS; Xu X
Adv Ther; 2010 Mar; 27(3):168-80. PubMed ID: 20429046
[TBL] [Abstract][Full Text] [Related]
36. CD44-mediated neutrophil apoptosis in the rat.
Takazoe K; Tesch GH; Hill PA; Hurst LA; Jun Z; Lan HY; Atkins RC; Nikolic-Paterson DJ
Kidney Int; 2000 Nov; 58(5):1920-30. PubMed ID: 11044212
[TBL] [Abstract][Full Text] [Related]
37. Induction of cell death by chimeric L-selectin-Fas receptors.
Ishiwatari-Hayasaka H; Kawashima H; Osawa T; Nagata S; Miyasaka M
Int Immunol; 1997 Apr; 9(4):627-35. PubMed ID: 9138024
[TBL] [Abstract][Full Text] [Related]
38. Hyaluronate-CD44 interactions can induce murine B-cell activation.
Rafi A; Nagarkatti M; Nagarkatti PS
Blood; 1997 Apr; 89(8):2901-8. PubMed ID: 9108410
[TBL] [Abstract][Full Text] [Related]
39. Cooperativity of CD44 and CD49d in leukemia cell homing, migration, and survival offers a means for therapeutic attack.
Singh V; Erb U; Zöller M
J Immunol; 2013 Nov; 191(10):5304-16. PubMed ID: 24127558
[TBL] [Abstract][Full Text] [Related]
40. Epitopes and functional responses defined by a panel of anti-Fas (CD95) monoclonal antibodies.
Komada Y; Inaba H; Li QS; Azuma E; Zhou YW; Yamamoto H; Sakurai M
Hybridoma; 1999 Oct; 18(5):391-8. PubMed ID: 10600025
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
